ERBB2 and triple-negative breast carcinoma: Young women also tend to have a higher proportion of aggressive subtypes such as  Human epidermal growth factor receptor 2 (HER2) amplified and triple negative breast cancer (TNBC) indicating difference in distribution of molecular subtypes9,10.